Right now, the U.S. Congress is considering the FDA Reauthorization Act of 2017 , legislation that will reauthorize the pharmaceutical, medical device, generic drug, and biosimilar user fee agreements. The five-year deal is one of the most important health care bills Congress will vote on this year.
On April 6, the U.S. Food and Drug Administration held a public meeting on Patient-Focused Drug Development (PFDD) for sarcopenia. The focus of the meeting was to obtain patient perspectives on “symptoms and the daily impacts of their condition, current approaches to treatment, and decision factors taken into account when selecting a treatment.”
On April 4, the Alliance for Aging Research’s Vice President of Public Policy Cynthia Bens will testify before the U.S. Senate Committee on Health, Education, Labor and Pensions about the reauthorization of the Prescription Drug User Fee Act and the Medical Device User Fee Act. You can watch the hearing here.
Millions of Americans use over-the-counter (OTC) pain medications for relief of minor aches and pains. One of the most commonly used types of OTC medications is acetaminophen. While acetaminophen is used quite often, it still carries risks. The Alliance has a collection of "pocket films" that offer you tips on safe usage of acetaminophen.
This Saturday, October 22, is National Prescription Drug Take-Back Day. The event, led by the U.S. Drug Enforcement Agency, encourages consumers to safely dispose of their unused prescription drugs. Learn more about the day and ways you can safely dispose of medications.
In response to a call from the U.S. Food and Drug Administration (FDA) for feedback on its proposed Commitment Letter for the sixth reauthorization of the Prescription Drug User Fee Act (PDUFA), the Alliance for Aging Research submitted comments to the FDA for consideration.
Last Friday, on June 10, Vice President of Public Policy Cynthia Bens presented comments on behalf of the Alliance at a U.S. Food and Drug Administration public meeting focused on OTC monograph user fees.
On April 7, the Alliance's Vice President of Public Policy Cynthia Bens will participate in a symposium titled "Frailty as a Baseline Stratification Parameter and Potential Therapeutic Target" at the 28th Annual EuroMeeting in Hamburg, Germany.
Older Americans make up 13% of our population but account for 34% of all prescription medication use and 30% of all over-the-counter (OTC) medication use. This is due in large part to the fact that 4 out of 5 older Americans has 1 or more chronic conditions—often requiring multiple medications at once.
On June 26, 2011 I was interviewed by BioCentury This Week to share the Alliance for Aging Research’s impressions on the fifth reauthorization of the Food and Drug Administration’s Prescription Drug User Fee program. Thanks to Congress, we and other active patient groups were able to lend an early voice in helping to shape how user fees might be used to help speed the delivery of better treatments and cures to patient in need of relief from Alzheimer’s, Cancer, Parkinson’s and many more diseases.
Sign up for our email newsletter, Living Longer & Loving It, for the latest information on scientific research on aging and health.